Home  »  Stock   »  Pfizer Inc. Inc. (PFE) Price Performance: A Techni...

Pfizer Inc. Inc. (PFE) Price Performance: A Technical Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -33.41%. However, over the last six months, the performance has been stronger by -15.48%. The price of PFE decreased -3.83% over the last 30 days. And in the last five days, it has fallen by -0.38%.

Pfizer Inc. (PFE) current stock price is $34.12. During the last trading session, the stock soared, reaching $34.38 after opening at $34.24. The stock’s lowest point was $33.98 before it closed at $34.15.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Pfizer Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $54.93 on 12/14/22, and the lowest price during that time was $33.54, recorded on 09/11/23.

52-week price history of PFE Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Pfizer Inc.’s current trading price is -37.88% away from its 52-week high, while its distance from the 52-week low is 1.73%. The stock’s price range for this period has been between $33.54 and $54.93. The Healthcare sector company’s shares saw a trading volume of about 9.86 million for the day, which was lower than the average daily volume of 24.44 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Pfizer Inc. (PFE) has experienced a quarterly decline of -14.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 192.81B and boasts a workforce of 83000 employees.

Expert Opinions: Analysts’ Ratings for Pfizer Inc.

As of right now, 10 analysts are rating Pfizer Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 36.97, with a change in price of -5.78. Similarly, Pfizer Inc. recorded 25,374,055 in trading volume during the last 100 days, posting a change of -14.50%.

PFE’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PFE stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.62.

PFE Stock Stochastic Average

As of today, the raw stochastic average of Pfizer Inc. over the past 50 days is 13.73%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 16.04%. Additionally, the Stochastic %K and %D values for the company were 15.86% and 15.37%, respectively, over the past 20 days.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts